Literature DB >> 9003380

High-affinity binding of laurate to naturally occurring mutants of human serum albumin and proalbumin.

U Kragh-Hansen1, A O Pedersen, M Galliano, L Minchiotti, S O Brennan, A L Tárnoky, M H Franco, F M Salzano.   

Abstract

Binding of laurate (n-dodecanoate) to genetic variants of albumin or its proprotein and to normal albumin isolated from the same heterozygous carriers was studied by a kinetic dialysis technique at physiological pH. The first stoichiometric association constant for binding to proalbumin Lille (Arg-2-->His) and albumin (Alb) Roma (Glu321-->Lys) was increased to 126% and 136% respectively compared with that for binding to normal albumin, whereas the constant for Alb Maku (Lys541-->Glu) was decreased to 80%. In contrast, normal laurate-binding properties were found for as many as nine other albumin variants with single amino acid substitutions. Because the net charges of all these mutants were different from that of normal albumin, the results suggest that the examples of modified laurate binding are not caused by long-range electrostatic effects. Rather, the three positions mentioned are located close to different binding sites for the fatty acid anion. The most pronounced effect was observed for the glycosylated Alb Casebrook, the binding constant of which was decreased to 20%. Binding to the glycosylated Alb Redhill was also decreased, but to a smaller extent (68%). These decreases in binding are caused by partial or total blocking of the high-affinity site by the oligosaccharides, by the negative charges of the oligosaccharides, and/or by conformational changes induced by these bulky moieties. Laurate binding to two chain-termination mutants (Alb Catania and Alb Venezia) was normal, indicating that the C-terminus of albumin is not important for binding. By using different preparations of normal albumin as controls in the binding experiments, it was also possible to compare the effect of various methods for isolation and defatting on laurate binding.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9003380      PMCID: PMC1218015          DOI: 10.1042/bj3200911

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  A comparative analysis of the binding of different long chain free fatty acids by human serum albumin.

Authors:  W D Wosilait; C Soler-Argilaga
Journal:  FEBS Lett       Date:  1977-01-15       Impact factor: 4.124

Review 2.  Structure of serum albumin.

Authors:  D C Carter; J X Ho
Journal:  Adv Protein Chem       Date:  1994

Review 3.  Molecular aspects of ligand binding to serum albumin.

Authors:  U Kragh-Hansen
Journal:  Pharmacol Rev       Date:  1981-03       Impact factor: 25.468

4.  Proalbumin Lille, a new variant of human serum albumin.

Authors:  Y Abdo; J Rousseaux; M Dautrevaux
Journal:  FEBS Lett       Date:  1981-08-31       Impact factor: 4.124

5.  Removal of fatty acids from serum albumin by charcoal treatment.

Authors:  R F Chen
Journal:  J Biol Chem       Date:  1967-01-25       Impact factor: 5.157

6.  Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11-22 of chromosome 4.

Authors:  P P Minghetti; D E Ruffner; W J Kuang; O E Dennison; J W Hawkins; W G Beattie; A Dugaiczyk
Journal:  J Biol Chem       Date:  1986-05-25       Impact factor: 5.157

7.  In vivo and in vitro binding of fatty acids to genetic variants of human serum albumin.

Authors:  U Kragh-Hansen; H Nielsen; A O Pedersen
Journal:  Int J Clin Pharmacol Res       Date:  1995

8.  Effects of ionic strength and pH on the binding of medium-chain fatty acids to human serum albumin.

Authors:  A O Pedersen; K L Mensberg; U Kragh-Hansen
Journal:  Eur J Biochem       Date:  1995-10-15

9.  Localization of the amino acid substitution site in a fast migrating variant of human serum albumin.

Authors:  P Iadarola; L Minchiotti; M Galliano
Journal:  FEBS Lett       Date:  1985-01-21       Impact factor: 4.124

10.  Protein and DNA sequence analysis of a 'private' genetic variant: albumin Ortonovo (Glu-505-->Lys).

Authors:  M Galliano; L Minchiotti; P Iadarola; M Stoppini; P Giagnoni; S Watkins; J Madison; F W Putnam
Journal:  Biochim Biophys Acta       Date:  1993-11-25
View more
  2 in total

Review 1.  Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties.

Authors:  K Oettl; R E Stauber
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

2.  Oxidation of human serum albumin exhibits inter-individual variability after an ultra-marathon mountain race.

Authors:  Ypatios Spanidis; Alexandros Priftis; Dimitrios Stagos; George A Stravodimos; Demetres D Leonidas; Demetrios A Spandidos; Aristides M Tsatsakis; Demetrios Kouretas
Journal:  Exp Ther Med       Date:  2017-03-28       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.